11 results
·
19ms
·
Sources: EU EUDAMED, US FDA
EMBRYO BIOPSY MEDIUM
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
Speedlock
FDA UDI
NATIONAL ADVANCED ENDOSCOPY DEVICES, INC.·00848657063272·Biopsy Punch, 5mm with Tooth Handle: 1358 Axia...
CHIBA NEEDLE
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
EBI XFIX DFS METAPHYSEAL CORRECTION SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
RADIESSE DERMAL FILLER
FDA Adverse Event
Injury
·MERZ AESTHETICS, INC. (FORMERY BIOFORM MEDICAL, INC.)·Product code LMH·November 22, 2010
FREESTYLE FLASH
FDA Adverse Event
Malfunction
·ABBOTT DIABETES CARE INC, USA·Product code LFR·May 29, 2007
LCS ROT PLAT BRNG STD+/10MM
FDA Adverse Event
Injury
·1818910 DEPUY ORTHOPAEDICS, INC.·Product code NJL·March 26, 2013
LS LTX FR CONV SOLST
FDA Adverse Event
Malfunction
·HOSPIRA COSTA RICA LTD.·Product code FPK·February 8, 2011
Belmont Rapid Infuser, a Fluid Management System, Model FMS2000.
FDA Enforcement
Class II
·Terminated·Belmont Instrument Corporation·October 24, 2012
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014